Vivatides Therapeutics
PrivateLast Round
Series A
Apr 10, 2026
Total Funding Raised
$64M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vivatides Therapeutics is a biotechnology company developing extrahepatic RNA-targeting therapeutics, including small interfering RNA (siRNA) and antisense oligonucleotides (ASOs), to treat chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivatides Therapeutics Comparables
Compare Vivatides Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creative Peptides | 79% | |
| BBI Life Sciences Corporation | 78% | |
| Medtide Inc | 76% | |
Vivatides Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 10, 2026 | ||||
| Seed | Aug 22, 2025 |
Vivatides Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Highlight Capital | Series A |
| TF Capital | Series A |
| Qiming Venture Partners | Seed, Series A |
| Apricot Capital | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
Raised $54M in Series A funding.
- Aug 22, 2025
$10M raised in Seed round.
Vivatides Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivatides Therapeutics's valuation, stock price, and market status.